BDBM50006818 CHEMBL3236951

SMILES: Cc1c(-c2cn(CC(C)(C)C)c(=O)c3ccccc23)c2cc(F)ccc2n1CC(O)=O

InChI Key: InChIKey=PQDMDOPPJQYUJM-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50006818   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
G protein-coupled receptor 44 (Homo sapiens (Human))	BDBM50006818 (CHEMBL3236951) Show SMILES Cc1c(-c2cn(CC(C)(C)C)c(=O)c3ccccc23)c2cc(F)ccc2n1CC(O)=O |(34.69,-56,;33.23,-56.48,;31.99,-55.57,;31.99,-54.03,;33.32,-53.27,;33.33,-51.73,;34.66,-50.96,;36,-51.73,;35.99,-53.27,;37.33,-50.96,;37.32,-52.49,;31.99,-50.95,;31.99,-49.41,;30.66,-51.73,;29.33,-50.97,;28,-51.74,;28.01,-53.28,;29.33,-54.04,;30.66,-53.27,;30.74,-56.48,;29.24,-56.16,;28.21,-57.3,;26.7,-56.98,;28.69,-58.76,;30.19,-59.08,;31.21,-57.94,;32.75,-57.94,;33.66,-59.19,;35.19,-59.03,;35.82,-57.62,;36.09,-60.28,)| Show InChI InChI=1S/C25H25FN2O3/c1-15-23(19-11-16(26)9-10-21(19)28(15)13-22(29)30)20-12-27(14-25(2,3)4)24(31)18-8-6-5-7-17(18)20/h5-12H,13-14H2,1-4H3,(H,29,30)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Antagonist activity at human recombinant CRTh2 expressed in CHO-K1 cells by cAMP TR FRET assay				J Med Chem 57: 1299-322 (2014) Article DOI: 10.1021/jm401509e BindingDB Entry DOI: 10.7270/Q21V5GGH
					More data for this Ligand-Target Pair
G protein-coupled receptor 44 (Homo sapiens (Human))	BDBM50006818 (CHEMBL3236951) Show SMILES Cc1c(-c2cn(CC(C)(C)C)c(=O)c3ccccc23)c2cc(F)ccc2n1CC(O)=O |(34.69,-56,;33.23,-56.48,;31.99,-55.57,;31.99,-54.03,;33.32,-53.27,;33.33,-51.73,;34.66,-50.96,;36,-51.73,;35.99,-53.27,;37.33,-50.96,;37.32,-52.49,;31.99,-50.95,;31.99,-49.41,;30.66,-51.73,;29.33,-50.97,;28,-51.74,;28.01,-53.28,;29.33,-54.04,;30.66,-53.27,;30.74,-56.48,;29.24,-56.16,;28.21,-57.3,;26.7,-56.98,;28.69,-58.76,;30.19,-59.08,;31.21,-57.94,;32.75,-57.94,;33.66,-59.19,;35.19,-59.03,;35.82,-57.62,;36.09,-60.28,)| Show InChI InChI=1S/C25H25FN2O3/c1-15-23(19-11-16(26)9-10-21(19)28(15)13-22(29)30)20-12-27(14-25(2,3)4)24(31)18-8-6-5-7-17(18)20/h5-12H,13-14H2,1-4H3,(H,29,30)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	18	n/a	n/a	n/a	n/a	n/a	25
Pfizer Inc. Curated by ChEMBL					Assay Description Antagonist activity at CRTh2 in human peripheral blood assessed as inhibition of PGD2-induced eosinophil shape change at room temperature by flow cyt...				J Med Chem 57: 1299-322 (2014) Article DOI: 10.1021/jm401509e BindingDB Entry DOI: 10.7270/Q21V5GGH
					More data for this Ligand-Target Pair